लोड हो रहा है...
Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway
Humoral immunity to factor VIII (FVIII) represents a significant challenge for the treatment of patients with hemophilia A. Current paradigms indicate that neutralizing antibodies against FVIII (inhibitors) occur through a classical CD4 T cell, germinal center (GC) dependent process. However, clinic...
में बचाया:
मुख्य लेखकों: | , , , , , , , , , , , |
---|---|
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Frontiers Media S.A.
2022-05-01
|
श्रृंखला: | Frontiers in Immunology |
विषय: | |
ऑनलाइन पहुंच: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.880829/full |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|